|
Southeast Asian Brugada Syndrome Cohort
RECRUITINGSponsored by Chulalongkorn University
Actively Recruiting
SponsorChulalongkorn University
Started2016-01-28
Est. completion2031-01-05
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04232787
Summary
Brugada syndrome (BrS) is the leading cause of sudden death in young Asian adults including Thailand. This syndrome may be hereditary and involve mutations in certain genes. Aim of the study is to identify the relationship between genetic variants and the diagnosis/clinical severity of patients with BrS.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: * Thai nationality * The patient has at least one of confirmed Brugada type 1 ECG in at least one of right precordial leads (v1 or v2) with or without pharmacologic provocative testing. The confirmed ECG is standard 12 lead ECG or Brugada lead Exclusion Criteria: * The patient has other cardiac diseases such as ischemic heart disease, valvular heart disease, congenital heart disease, myocarditis and pericarditis * The patient has type 2 or type 3 Brugada ECG without type 1 ECG during pharmacologic provocative testing and/or Brugada lead * The patient had one time of Brugada type 1 ECG during drug use without reproducibility
Conditions2
Brugada SyndromeHeart Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorChulalongkorn University
Started2016-01-28
Est. completion2031-01-05
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04232787